WellPoint Swears Off Switch Petitions; Antihistamine Campaign Had PR Costs

The adverse publicity surrounding WellPoint's petition to force an OTC switch of nonsedating antihistamines has convinced the insurer not to pursue similar efforts in the future, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman told a recent IIR conference in Philadelphia

More from Archive

More from Pink Sheet